Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $258,282 | 82 | 60.7% |
| Consulting Fee | $104,771 | 46 | 24.6% |
| Travel and Lodging | $40,582 | 81 | 9.5% |
| Food and Beverage | $21,319 | 751 | 5.0% |
| Education | $643.46 | 11 | 0.2% |
| Honoraria | $8.11 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $124,634 | 206 | $0 (2024) |
| GENZYME CORPORATION | $65,219 | 74 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $51,686 | 109 | $0 (2024) |
| PFIZER INC. | $49,676 | 78 | $0 (2024) |
| Galderma Laboratories, L.P. | $37,054 | 72 | $0 (2024) |
| LEO Pharma Inc. | $29,180 | 69 | $0 (2024) |
| Lilly USA, LLC | $18,281 | 41 | $0 (2024) |
| Verrica Pharmaceuticals Inc. | $17,372 | 22 | $0 (2024) |
| UCB, Inc. | $11,551 | 28 | $0 (2024) |
| Janssen Biotech, Inc. | $8,403 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $379,064 | 638 | ABBVIE INC. ($111,767) |
| 2023 | $45,515 | 290 | Arcutis Biotherapeutics, Inc. ($13,979) |
| 2022 | $1,027 | 44 | E.R. Squibb & Sons, L.L.C. ($211.60) |
All Payment Transactions
972 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,420.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $184.34 | General |
| Category: Dermatology | ||||||
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.28 | General |
| Category: Immunology | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $3.48 | General |
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $49.28 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.47 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| 12/11/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 12/10/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Immunology | ||||||
| 12/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $82.17 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: Immunology | ||||||
| 12/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Galderma Laboratories, L.P. | — | Travel and Lodging | Cash or cash equivalent | $324.90 | General |
| 12/05/2024 | Galderma Laboratories, L.P. | — | Travel and Lodging | Cash or cash equivalent | $146.97 | General |
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Galderma Laboratories, L.P. | — | Travel and Lodging | Cash or cash equivalent | $24.00 | General |
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.58 | General |
| 12/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.63 | General |
| 12/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.54 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 50 | 4,415 | 11,593 | $2.8M | $488,706 |
| 2022 | 25 | 1,459 | 2,383 | $629,456 | $137,813 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 533 | 862 | $320,664 | $77,223 | 24.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 419 | 578 | $424,431 | $72,774 | 17.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 493 | 604 | $253,076 | $44,955 | 17.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 75 | 95 | $156,714 | $30,679 | 19.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 69 | 80 | $195,086 | $28,066 | 14.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 342 | 416 | $109,408 | $24,612 | 22.5% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 65 | 80 | $96,110 | $22,439 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 187 | 187 | $88,638 | $20,287 | 22.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 413 | 494 | $149,993 | $16,076 | 10.7% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 104 | 139 | $52,525 | $11,958 | 22.8% |
| 11303 | Shaving of skin growth of body, arms, or legs, more than 2.0 cm | Office | 2023 | 85 | 105 | $49,178 | $11,174 | 22.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 173 | 192 | $72,576 | $10,903 | 15.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 111 | 111 | $35,631 | $7,381 | 20.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 285 | 1,406 | $118,104 | $7,208 | 6.1% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2023 | 48 | 59 | $78,976 | $7,203 | 9.1% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 24 | 33 | $23,209 | $6,604 | 28.5% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 18 | 21 | $9,771 | $6,431 | 65.8% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 19 | 4,800 | $9,000 | $6,213 | 69.0% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 46 | 56 | $59,480 | $6,143 | 10.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 66 | 68 | $32,300 | $6,093 | 18.9% |
| 11312 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 37 | 42 | $18,378 | $4,419 | 24.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 55 | 103 | $21,115 | $4,083 | 19.3% |
| 11606 | Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | Office | 2023 | 12 | 13 | $25,353 | $4,023 | 15.9% |
| 17106 | Destruction of birthmark, less than 10.0 sq cm | Office | 2023 | 13 | 13 | $17,468 | $3,504 | 20.1% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 34 | 44 | $16,452 | $3,467 | 21.1% |
About Dr. Diego Dasilva, MD
Dr. Diego Dasilva, MD is a Dermatology healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2018. The National Provider Identifier (NPI) number assigned to this provider is 1912499047.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Diego Dasilva, MD has received a total of $425,606 in payments from pharmaceutical and medical device companies, with $379,064 received in 2024. These payments were reported across 972 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($258,282).
As a Medicare-enrolled provider, Dasilva has provided services to 5,874 Medicare beneficiaries, totaling 13,976 services with total Medicare billing of $626,520. Data is available for 2 years (2022–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Virginia Beach, VA
- Active Since 06/04/2018
- Last Updated 10/13/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1912499047
Products in Payments
- RINVOQ (Biological) $94,225
- DUPIXENT (Biological) $66,550
- CIBINQO (Drug) $40,321
- Zoryve (Drug) $37,707
- ADBRY (Biological) $26,019
- SKYRIZI (Biological) $24,948
- OLUMIANT (Drug) $17,539
- YCANTH (Drug) $17,372
- Bimzelx (Biological) $10,253
- LITFULO (Drug) $8,918
- TREMFYA (Drug) $8,464
- VTAMA (Drug) $7,580
- Sotyktu (Drug) $1,432
- EUCRISA (Drug) $424.73
- OPZELURA (Drug) $349.02
- Otezla (Drug) $272.87
- TALTZ (Drug) $264.90
- COSENTYX (Drug) $239.11
- Enbrel (Biological) $209.62
- Xeomin (Biological) $171.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Virginia Beach
Dr. Tara Buehler-Bota, M.d, M.D
Dermatology — Payments: $18,613
Padman Menon, M.d, M.D
Dermatology — Payments: $14,633
Mrs. Kimberly Soderberg, Md, MD
Dermatology — Payments: $10,921
Beatrix Edmonds, Md, MD
Dermatology — Payments: $10,689
Dr. Michael Gross, M.d, M.D
Dermatology — Payments: $8,477
Dr. George Harr, M.d, M.D
Dermatology — Payments: $6,612